Capsovision, INC Form 4 insider transactions

NASDAQ
CapsoVision, Inc. Director Wen-Herng Henry King received an award of 2,887 Restricted Stock Units, scheduled to vest by December 31, 2025.
NASDAQ
CapsoVision Director Joanne Imperial received a grant of 2,887 Restricted Stock Units, scheduled to vest by December 31, 2025.
NASDAQ
CapsoVision Director Julia S. Gouw acquired 2,887 Restricted Stock Units, scheduled to vest on December 31, 2025, under a Rule 10b5-1 plan.
NASDAQ
CapsoVision Director Michele Harari acquired 2,887 Restricted Stock Units and holds 56,156 common shares following a recent reverse stock split and IPO.
NASDAQ
CapsoVision's Director of Clinical Affairs exercised stock options for 24,834 shares following a reverse stock split and IPO.
NASDAQ
Eliyahou Harari, a Director and 10% owner of CapsoVision, Inc., reported the automatic conversion of millions of preferred shares into common stock following the company's initial public offering and a reverse stock split.
NASDAQ
Eliyahou Harari, a Director and 10% owner of CapsoVision, Inc., reported the conversion of millions of preferred shares into common stock following the company's initial public offering and a reverse stock split.
NASDAQ
CapsoVision, Inc. Director Wen-Herng Henry King converted 68,966 shares of Series H Preferred Stock into 20,710 shares of Common Stock following the company's initial public offering and a reverse stock split.
NASDAQ
CapsoVision Director Hui Ying Kuo converted 34,482 shares of Series H Preferred Stock into 10,354 shares of Common Stock on July 3, 2025, following the company's initial public offering and a reverse stock split.
NASDAQ
CapsoVision, Inc. Director Chen Lung Tsai converted various series of preferred stock into common shares, increasing his indirect beneficial ownership to 115,456 common shares following the company's initial public offering and a 1-for-3.33 reverse stock split.
NASDAQ
CapsoVision, Inc. CEO Kang-Huai Wang converted all his preferred stock holdings into common shares following the company's initial public offering, now beneficially owning 721,732 common shares.